Vit Vasista was Appointed as Chief Financial Officer at Regenxbio

Date of management change: May 20, 2015 

What Happened?

Washington, DC-based Regenxbio Appointed Vit Vasista as Chief Financial Officer

 

About the Company

Regenxbio was formed from a successful collaboration that began in February 2009 between FoxKiser LLP, the University of Pennsylvania and gene therapy pioneer James M. Wilson, M.D., Ph.D. The foundation of our NAV Technology Platform was discovered in an effort to identify next generation AAV vectors that could overcome the limitations of earlier generation AAV vectors (AAV1 through AAV6).

 

About the Person

Vit Vasista is the Chief Financial Officer and Senior Vice President of Corporate Development at REGENXBIO. Prior to joining REGENXBIO, Mr. Vasista served as Principal at PRTM Management Consultants, where he developed operational strategies for both private and public organizations, including the development of market entry strategies, innovative business models, and operational improvements.

 

Info Source

Company Announcement

 
 

Other IT executives who recently changed jobs as well: Madetzke Troy, Flores Sylvia, Cole Jeff, Stewart Katie, Fanning Paul, Pomaville Paula, High Robert, Lokesh Sheetal, Araujo Lisa, Berdichevsky Gene, Barbour Tam

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.